NCT00996112

Brief Summary

The goal of this study is to further the investigators' understanding of community acquired methicillin-resistant Staph Aureus (CA-MRSA) and treatment of it by developing real-world sustainable strategies consistent with existing guidelines on treatment of CA-MRSA from the Centers for Disease Control and Prevention (CDC) and test these strategies in busy primary care settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,518

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 16, 2009

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2010

Completed
Last Updated

January 25, 2013

Status Verified

November 1, 2010

Enrollment Period

7 months

First QC Date

October 15, 2009

Last Update Submit

January 23, 2013

Conditions

Methicillin-Resistant Staphylococcus Aureus

Keywords

primary health care

Outcome Measures

Primary Outcomes (1)

  • Physician Behavior Change

    Intervention in practice for guideline-concordant care of CA MRSA

    Throughout study participation

Study Arms (2)

Historical

Prospective

Eligibility Criteria

AgeUp to 89 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population comprises primary care patients in ambulatory clinics from two health care systems.

You may qualify if:

  • All patients presenting at a primary care clinic who have a skin or soft tissue infection.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver

Aurora, Colorado, 80045, United States

Location

Study Officials

  • David R West, PhD

    Department of Family Medicine, University of Colorado Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2009

First Posted

October 16, 2009

Study Start

October 1, 2009

Primary Completion

May 1, 2010

Study Completion

August 1, 2010

Last Updated

January 25, 2013

Record last verified: 2010-11

Locations

US(1)